Sodium hydride → (R)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl 4-(4-trifluoromethylphenoxy)piperidine-1-carboxylate
反応式
[F:1][C:2]([F:34])([F:33])[C:3]1[CH:32]=[CH:31][C:6]([O:7][CH:8]2[CH2:13][CH2:12][N:11]([C:14]([O:16][CH2:17][C@@:18]([OH:30])([CH3:29])[CH2:19][N:20]3[CH:24]=[C:23]([N+:25]([O-:27])=[O:26])[N:22]=[C:21]3Cl)=[O:15])[CH2:10][CH2:9]2)=[CH:5][CH:4]=1.[H-].[Na+]>CN(C=O)C>[F:1][C:2]([F:34])([F:33])[C:3]1[CH:32]=[CH:31][C:6]([O:7][CH:8]2[CH2:13][CH2:12][N:11]([C:14]([O:16][CH2:17][C@:18]3([CH3:29])[O:30][C:21]4=[N:22][C:23]([N+:25]([O-:27])=[O:26])=[CH:24][N:20]4[CH2:19]3)=[O:15])[CH2:10][CH2:9]2)=[CH:5][CH:4]=1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
To the solution of (R)-3-(2-chloro-4-nitroimidazol-1-yl)-2-hydroxy-2-methylpropyl 4-(4-trifluoromethylphenoxy)piperidine-1-carboxylate prepared in Example 104 (0.18 g, 0.36 mmol) in DMF (2 ml), sodium hydride (19 mg, 0.47 mmol) was added followed by stirring for 1.5 hours with cooling on ice-bath. To the reaction mixture, ice-water was added, and the solution was extracted with ethyl acetate. The organic phase was washed with water, dried over magnesium sulfate and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (methylene chloride/ethyl acetate=9/1) and recrystallized from isopropanol to afford (R)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl 4-(4-trifluoromethylphenoxy)piperidine-1-carboxylate (0.08 g, yield 47%) as a white solid.
後処理
- temperaturewith cooling on ice-bath
- extractionthe solution was extracted with ethyl acetate
- washThe organic phase was washed with water
- dry with materialdried over magnesium sulfate
- concentrationconcentrated under reduced pressure
- customThe residue was purified by silica gel column chromatography (methylene chloride/ethyl acetate=9/1)
- customrecrystallized from isopropanol
出典と根拠
- ORDレコード
- ord-663684a4030f4d649487c571af0faa2e
- 出典データセット
- uspto-grants-2007_08
- 特許番号
- US07262212B2
反応ノート
読み込み中…